Hemoglobinopathies (structural defects in hemoglobin)
TR Randolph - … hematology: clinical principles and application. St …, 2019 - books.google.com
1. Explain the difference between structural hemoglobin disorders and thalassemias, and
describe the types of mutations found in the structural disorders. 2. Describe globin gene …
describe the types of mutations found in the structural disorders. 2. Describe globin gene …
Chronic myelocytic leukemia–Part I: History, clinical presentation, and molecular biology
TR Randolph - American Society for Clinical Laboratory Science, 2005 - clsjournal.ascls.org
DATA SOURCES: Current literature. DATA SYNTHESIS: Chronic myelocytic leukemia (CML)
was initially described in 1845 and is considered one of the first leukemias to be discovered…
was initially described in 1845 and is considered one of the first leukemias to be discovered…
Acute promyelocytic leukemia (AML-M3)-part 1: Pathophysiology, clinical diagnosis, and differentiation therapy
TR Randolph - Clinical Laboratory Science, 2000 - search.proquest.com
The objectives of this review paper are to: Compare acute leukemia with chronic leukemia
and other forms of cancer. Review the pathophysiology and discuss the clinical and …
and other forms of cancer. Review the pathophysiology and discuss the clinical and …
Advances in acute lymphoblastic leukemia
TR Randolph - American Society for Clinical Laboratory Science, 2004 - clsjournal.ascls.org
DATA SOURCES: Current literature DATA SYNTHESIS: Acute lymphoblastic leukemia (ALL)
is a stem cell disorder characterized by an overproduction of lymphoblasts in the bone …
is a stem cell disorder characterized by an overproduction of lymphoblasts in the bone …
Novel test method (sickle confirm) to differentiate sickle cell anemia from sickle cell trait for potential use in developing countries
TR Randolph, J Wheelhouse - American Society for Clinical …, 2012 - clsjournal.ascls.org
The objective of this study was to develop a diagnostic testing method to detect HbS, distinguish
sickle cell homozygotes from heterozygotes, and overcome testing barriers encountered …
sickle cell homozygotes from heterozygotes, and overcome testing barriers encountered …
Estimated prevalence of sickle cell in northern Haiti
TR Randolph - American Society for Clinical Laboratory Science, 2010 - clsjournal.ascls.org
OBJECTIVE: The purpose of this study is to estimate the prevalence of sickle hemoglobin in
northern Haiti. DESIGN: Sickle cell testing occurred from 2002-2009. Blood samples from …
northern Haiti. DESIGN: Sickle cell testing occurred from 2002-2009. Blood samples from …
Chronic myelocytic leukemia–part II: approaches to and molecular monitoring of therapy
TR Randolph - American Society for Clinical Laboratory Science, 2005 - clsjournal.ascls.org
DATA SOURCES: Current literature. DATA SYNTHESIS: Chronic myelocytic leukemia (CML)
was initially described in 1845 and is considered one of the first leukemias discovered. …
was initially described in 1845 and is considered one of the first leukemias discovered. …
[PDF][PDF] Pathophysiology of compound heterozygotes involving hemoglobinopathies and thalassemias
TR Randolph - Clinical Laboratory Science, 2008 - clsjournal.ascls.org
… TIM R RANDOLPH … Tim R Randolph PhD MT(ASCP) CLS(NCA) is associate … Address for
Correspondence:Tim R Randolph MS MT(ASCP) CLS(NCA), associate professor, Department …
Correspondence:Tim R Randolph MS MT(ASCP) CLS(NCA), associate professor, Department …
Acute promyelocytic leukemia (AML-M3)-part 2: molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy
TR Randolph - Clinical Laboratory Science, 2000 - search.proquest.com
To identify the chromosomal translocation common in M3 and discuss its diagnostic use to:
Compare acute leukemia with chronic leukemia and other forms of cancer. Describe the …
Compare acute leukemia with chronic leukemia and other forms of cancer. Describe the …
Development of a micro-ESR system with potential for in-home use
SE Douglas, TR Randolph - American Society for Clinical …, 2007 - clsjournal.ascls.org
OBJECTIVE: To develop a micro-erythrocyte sedimentation rate (ESR) system with potential
to be self-administered by patients at home using capillary blood. DESIGN: For each subject…
to be self-administered by patients at home using capillary blood. DESIGN: For each subject…